The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil: 26 (SpringerBriefs in Political Science, 26) - Image 1

£40.18

Springer The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil: 26 (SpringerBriefs in Political Science, 26)

Name: The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil: 26 (SpringerBriefs in Political Science, 26)
Brand: Springer
Price: 40.18 GBP
Availability: InStock

Economic Conditions

This is the most expensive it has ever been. Walk away.

£40 today · previous high £40 · all-time low £37

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 637 days • 637 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 637 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £39 (339 days, 53.2%)

Price range: £37 - £40

Price levels: 3 different prices over 637 days

Description

Brazil is renowned worldwide for its remarkable reforms in pharmaceutical regulation, which have enhanced access to essential medicines while lowering drug costs. This book innovates by analysing the generic drug reform in Brazil, demonstrating that pharmaceutical regulation is only partially influenced by non-state actors. Little is known about the institutional antecedents and policy process that channeled this regulatory reform. This is particularly intriguing because a regulatory shift in the pharmaceutical sector requires the participation of a number of stakeholders and interest groups in the policy process. Fonseca examines the generic drug reform’s causes and consequences. No study has approached the generic drug regulation in Brazil from this perspective. The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil, explores the following: · The politics of pharmaceutical regulation in Brazil over the last 25 years. · The political negotiations to approve the Generic Drug Act, which involved a hard-to-reach agreement between the pharmaceutical industry (national and multinational), the Ministry of Health, and Congress · The controversial decisions to regulate packaging and pharmaceutical equivalence. · The surprising success of Brazilian pharmaceutical firms, which became market champions in a sector largely dominated by multinational firms. · Comparative lessons from the Brazilian case for the political construction of regulatory standards to regulate generic drugs and its effects on global health. This book will interest political scientists and health policy scholars concerned with the political conflicts in the pharmaceutical sector. It argues against well-established approaches to regulatory capture such as control of the regulatory process by interest groups and policy diffusion. It can be used as evidence for graduate courses in public policy, health policy and political science. Because Brazil is one of the largest markets for pharmaceuticals in the world, business leaders and consultancy firms would also be interested.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 3319125648
Category: Books > Subjects > Business, Finance & Law > Economics > Economic Conditions
Domain: Amazon UK
Release Date: 01 December 2014
Listed Since: 18 September 2014

Barcode

No barcode data available

Springer The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil: 26 (SpringerBriefs in Political Science, 26)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

PHARMACEUTICAL ECONOMICS AND POLICY 3RD EDITION: Perspectives, Promises, and Problems

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

The Pharmaceutical Industry: A Guide to Historical Records (Studies in British Business Archives)

Global Issues in Pharmaceutical Marketing

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Pharmaceuticals, Corporate Crime and Public Health

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Generic Drug Product Development: Solid Oral Dosage Forms, Second Edition: 129 (Drugs and the Pharmaceutical Sciences)

The Public Financing of Pharmaceuticals: An Economic Approach

Government, Big Pharma, and The People: A Century of Dis-Ease

Poor Quality Pharmaceuticals in Global Public Health: 5 (Trust, 5)

EU Law of Competition and Trade in the Pharmaceutical Sector (Elgar Competition Law and Practice series)

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Pharmaceutical Public Policy

World Pharmaceutical Industry

The Future of Pharma: Evolutionary Threats and Opportunities

The Future of Pharma: Evolutionary Threats and Opportunities

Routledge Pharmaceutical Industry and Public Policy in India

The Law of Off-label Uses of Medicines: Regulation and Litigation in the EU, UK and USA

Routledge: The Japanese Pharmaceutical Industry Evolution Book

Guide to EU Pharmaceutical Regulatory Law

Illicit Medicines in the Global South: Public Health Access and Pharmaceutical Regulation (Routledge Global Health Series)